More subprime writedowns at Morgan Stanley
Morgan Stanley has taken a total of $9.4 billion in mortgage-related writedowns in the fourth quarter, causing it to lose $3.6 billion, it announced today.
The desk made a large illiquid trade in the mortgage market, and then decided to hold the position rather than unwind it and take losses. "But the hedges did not perform well in late October and early November, given the illiquidity of the position," Mack said.
Chief financial officer Colm Kelleher said that the the mortgage desk had decided to short the subprime market by taking a $2 billion short position in low-rated subprime mortgage-backed securities (MBS). In order to meet the cost of the negative carry of the short position, the desk also went long $14 billion of AAA-rated super-senior [tranches] of BBB subprime securities, which we refer to as mezzanine," he said. The investment in the top tranches of collateralised debt obligations (CDOs) of MBS was assumed to be safe enough to provide a reliable source of funding to meet the cost of the short position, even if the underlying market declined.
But, he added, losses on US subprime mortgages had been severe enough to eat into the value of even these AAA-rated CDO tranches. "The losses were non-linear in relation to the ABX because of the long-short structure," he added.
Morgan Stanley had earlier reported mortgage-related writedowns of $3.7 billion in October, but added another $5.7 billion - including $4.1 billion related to US subprime residential mortgages - in November. The quarter ended on November 30.
The bulk of the $9.4 billion represents mark-to-market losses on residential mortgage exposure. However, it also includes $400 million lost on commercial mortgage-backed securities (CMBS) in November, which, Mack said, was a "realised loss".
In a note issued today, Credit Suisse warned CMBS writedowns could "generate substantial losses". Lehman Brothers, Credit Suisse and Wachovia have all announced losses on CMBS exposure, and the rising CMBX index "suggests further writedowns could be coming from other large banks", wrote analyst Daniel Davies. Morgan Stanley was the largest issuer of CMBS in the first half of the year, issuing $26.8 billion-worth. Based on this, Davies argued, its exposure was likely to be "roughly proportionate". Other large issuers were Wachovia ($20.6 billion), JP Morgan Chase ($18.8 billion), Credit Suisse ($17 billion) and Deutsche Bank ($13.9 billion).
Morgan Stanley also announced an agreement with China Investment Corporation, under which CIC would take a 9.9% stake in the bank in the form of convertible instruments. The instruments will yield a 9% annual payment until their conversion in August 2010, and will provide Morgan Stanley with a 20% premium.
See also:Banks reveal further subprime wounds
$400 billion losses on subprime, predicts Deutsche Bank
Credit and liquidity risk hammer earnings
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@risk.net
More on Structured products
A guide to home equity investments: the untapped real estate asset class
This report covers the investment opportunity in untapped home equity and the growth of HEIs, and outlines why the current macroeconomic environment presents a unique inflection point for credit-oriented investors to invest in HEIs
Podcast: Claudio Albanese on how bad models survive
Darwin’s theory of natural selection could help quants detect flawed models and strategies
Range accruals under spotlight as Taiwan prepares for FRTB
Taiwanese banks review viability of products offering options on long-dated rates
Structured products gain favour among Chinese enterprises
The Chinese government’s flagship national strategy for the advancement of regional connectivity – the Belt and Road Initiative – continues to encourage the outward expansion of Chinese state-owned enterprises (SOEs). Here, Guotai Junan International…
Structured notes – Transforming risk into opportunities
Global markets have experienced a period of extreme volatility in response to acute concerns over the economic impact of the Covid‑19 pandemic. Numerix explores what this means for traders, issuers, risk managers and investors as the structured products…
Structured products – Transforming risk into opportunities
The structured product market is one of the most dynamic and complex of all, offering a multitude of benefits to investors. But increased regulation, intense competition and heightened volatility have become the new normal in financial markets, creating…
Increased adoption and innovation are driving the structured products market
To help better understand the challenges and opportunities a range of firms face when operating in this business, the current trends and future of structured products, and how the digital evolution is impacting the market, Numerix’s Ilja Faerman, senior…
Structured products – The ART of risk transfer
Exploring the risk thrown up by autocallables has created a new family of structured products, offering diversification to investors while allowing their manufacturers room to extend their portfolios, writes Manvir Nijhar, co-head of equities and equity…